P-glycoprotein and its role in drug-drug interactions
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Efflux transporters such as P-glycoprotein play an important role in drug transport in many organs.In the gut, P-glycoprotein pumps drugs back into the lumen, decreasing their absorption.Drugs which induce P-glycoprotein, such as rifampicin, can reduce the bioavailability of some other drugs.Inhibitors of P-glycoprotein, such as verapamil, increase the bioavailability of susceptible drugs.Many, but not all, of the drugs which are transported by P-glycoprotein are also metabolised by cytochrome P450 3A4.Important substrates of P-glycoprotein include calcium channel blockers, cyclosporin, dabigatran etexilate, digoxin, erythromycin, loperamide, protease inhibitors and tacrolimus.Predicting clinically important interactions is difficult because of interindividual differences in drug transport. Drug absorptionThe epithelial cell lining of the small intestine is not just a site for drug absorption, but also an important barrier to the absorption of xenobiotics.P-glycoprotein is found in the apical (luminal) membrane of the entire intestine from duodenum to rectum, with a high expression in the enterocytes of the small intestine.It reduces the oral availability of drugs that are its substrates.3,4 Like the enzymes involved in drug metabolism, substrates of P-glycoprotein can potentially act as inhibitors or inducers of its function.Inhibition of P-glycoprotein can result in increased bioavailability of the susceptible drug.Induction of P-glycoprotein reduces the bioavailability. Drug distributionOnce a drug has reached the systemic circulation, P-glycoprotein further limits penetration into a number of sensitive tissues.P-glycoprotein is also important for the blood-brain barrier as a defence against the penetration of toxins and drugs into the central nervous system.3 Drug elimination P-glycoprotein has a modest role in drug elimination.It is expressed in the luminal membrane of proximal tubule cells in the kidneys.P-glycoprotein pumps drugs into the urine. Drug interactionsP-glycoprotein is an important mediator of drug-drug interactions.3 The pharmacokinetics of a drug may
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
Cited by
Noreen, S., Hasan, S., Ghumman, S. A., Anwar, S., Gondal, H. Y., Batool, F., & Noureen, S. (2023) · ACS Omega · doi:10.1021/acsomega.2c07789 · Cited by 22
Metadata
- Authors
- Finch, A., & Pillans, P.
- Venue
- Australian Prescriber
- Publisher
- Therapeutic Guidelines Limited
- Published
- 2014-08-01
- Volume
- 37
- Issue
- 4
- Pages
- 137-139
- ISSN
- 0312-8008 (ISSN-L)
- 1839-3942
- OpenAlex
- W124822842
- Cited by
- 230
- References
- 2
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: P-glycoprotein and its role in drug-drug interactions. https://app.cochat.ai/papers/10.18773/austprescr.2014.050
- The paper
- Finch, A., & Pillans, P. (2014). P-glycoprotein and its role in drug-drug interactions. Australian Prescriber. https://doi.org/10.18773/austprescr.2014.050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.